Latest developments and challenges in the diagnosis of human West Nile virus infection

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 3, 2015, Pages 327-342

  Barzon, Luisa ^a   Pacenti, Monia ^b   Ulbert, Sebastian ^c   Palù, Giorgio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

blood; diagnosis; human; molecular test; neutralization test; serology test; serum; test performance; urine; West Nile virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NONSTRUCTURAL PROTEIN 1; VIRUS VACCINE; VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLADISTICS; CLINICAL FEATURE; DIAGNOSTIC KIT; DIARRHEA; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FATIGUE; FEVER; FLAVIVIRUS INFECTION; GENE SEQUENCE; GENETIC VARIABILITY; HEADACHE; HUMAN; INCUBATION TIME; LYMPHADENOPATHY; MACULOPAPULAR RASH; MASS SPECTROMETRY; METAGENOMICS; MOLECULAR EPIDEMIOLOGY; MYALGIA; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PARALYSIS; PHYLOGENY; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; VOMITING; WEST NILE FLAVIVIRUS; ANTIBODY AFFINITY; BLOOD; CROSS REACTION; EPIDEMIC; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; NORTH AMERICA; SERODIAGNOSIS; SEROLOGY; WEST NILE FEVER; WEST NILE VIRUS;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CROSS REACTIONS; DISEASE OUTBREAKS; EUROPE; HUMANS; NEUTRALIZATION TESTS; NORTH AMERICA; SEROLOGIC TESTS; VIRAL LOAD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84922979784     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.1007044     Document Type: Article

References (148)

1. Suthar MS, Diamond MS, Gale M Jr. West Nile virus infection and immunity. Nat Rev Microbiol 2013;11:115-28
2. Chung WM, Buseman CM, Joyner SN, et al. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 2013;310:297-307
3. Gobbi F, Capelli G, Angheben A, et al. Human and entomological surveillance of West Nile fever, dengue and chikungunya in Veneto Region, Italy, 2010-2012. BMC Infect Dis 2014;14:60
4. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA 2013;310:308-15
5. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940;20:471-2
6. Di Sabatino D, Bruno R, Sauro F, et al. Epidemiology of West Nile disease in Europe and in the Mediterranean Basin from 2009 to 2013. Biomed Res Int 2014;2014:907852
7. Mann BR, McMullen AR, Swetnam DM, Barrett ADT. Molecular epidemiology and evolution of West Nile virus in North America. Int J Environ Res Public Health 2013;10:5111-29
8. Pesko KN, Ebel GD. West Nile virus population genetics and evolution. Infect Genet Evol 2012;12:181-90
9. Bakonyi T, Ivanics E, Erdélyi K, et al. Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis 2006;12:618-23.
10. Bakonyi T, Hubá lek Z, Rudolf I, Nowotny N. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis 2005;11:225-31
11. Vazquez A, Sanchez-Seco MP, Ruiz S, et al. Putative new lineage of West Nile virus, Spain. Emerg Infect Dis 2010;16:549-52
12. Pachler K, Lebl K, Berer D, et al. Putative new West Nile virus lineage in Uranotaenia unguiculata mosquitoes, Austria, 2013. Emerg Infect Dis 2014;20:2119-22
13. Bondre VP, Jadi RS, Mishra AC, et al. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol 2007;88:875-84
14. Lvov DK, Butenko AM, Gromashevsky VL, et al. West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations. Arch Virol Suppl 2004;18:85-96
15. Fall G, Diallo M, Loucoubar C, et al. Vector competence of Culex neavei and Culex quinquefasciatus (Diptera: Culicidae) from Senegal for lineages 1, 2, Koutango and a putative new lineage of West Nile virus. Am J Trop Med Hyg 2014;90:747-54
16. Brault AC, Huang CY, Langevin SA, et al. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet 2007;39:1162-6
17. Barzon L, Franchin E, Squarzon L, et al. Genome sequence analysis of the first human West Nile virus isolated in Italy in 2009. Euro Surveill 2009;14:pii: 19384
18. Lim SM, Koraka P, van Boheemen S, et al. Characterization of the mouse neuroinvasiveness of selected European strains of West Nile virus. PLoS One 2013;8:e74575
19. Frost MJ, Zhang J, Edmonds JH, et al. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg Infect Dis 2012;18:792-800
20. Venter M, Human S, Zaayman D, et al. Lineage 2 West Nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis 2009;15:877-84
21. Bakonyi T, Ferenczi E, Erdélyi K, et al. Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009. Vet Microbiol 2013;165:61-70
22. Wodak E, Richter S, Bago- Z, et al. Detection and molecular analysis of West Nile virus infections in birds of prey in the eastern part of Austria in 2008 and 2009. Vet Microbiol 2011;149:358-66
23. Papa A, Bakonyi T, Xanthopoulou K, et al. Genetic characterization of West Nile virus lineage 2, Greece, 2010. Emerg Infect Dis 2011;17:920-2
24. Popović N, Milošević B, Urošević A, et al. Outbreak of West Nile virus infection among humans in Serbia, August to October 2012. Euro Surveill 2013;18:pii: 20613
25. Petrović T, Blazquez AB, Lupulović D, et al. Monitoring West Nile virus (WNV) infection in wild birds in Serbia during 2012: first isolation and characterisation of WNV strains from Serbia. Euro Surveill 2013;18:pii: 20622
26. Barzon L, Papa A, Pacenti M, et al. Genome sequencing of West Nile Virus from human cases in Greece, 2012. Viruses 2013;5:2311-19
27. Papa A. West Nile virus infections in Greece: an update. Expert Rev Anti Infect Ther 2012;10:743-50
28. Pervanidou D, Detsis M, Danis K, et al. West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmission. Euro Surveill 2014;19:pii: 20758
29. Kemenesi G, Krtinić B, Milankov V, et al. West Nile virus surveillance in mosquitoes, April to October 2013, Vojvodina province, Serbia: implications for the 2014 season. Euro Surveill 2014;19:pii:20779
30. Barzon L, Pacenti M, Franchin E, et al. Whole genome sequencing and phylogenetic analysis of West Nile virus lineage 1 and lineage 2 from human cases of infection, Italy, August 2013. Euro Surveill 2013;18: pii: 20591.
31. PlatonovAE, Fedorova MV, Karan LS, et al. Epidemiology of West Nile infection in Volgograd, Russia, in relation to climate change and mosquito (Diptera: Culicidae) bionomics. Parasitol Res 2008;103(Suppl 1):S45-53
32. Sirbu A, Ceianu CS, Panculescu-Gatej RI, et al. Outbreak of West Nile virus infection in humans, Romania, July to October 2010. Euro Surveill 2011;16:pii: 19762
33. Kolodziejek J, Marinov M, Kiss BJ, et al. The complete sequence of a West Nile virus lineage 2 strain detected in a Hyalomma marginatum marginatum tick collected from a song thrush (Turdus philomelos) in Eastern Romania in 2013 revealed closest genetic relationship to strain Volgograd 2007. PLoS One 2014;9:e109905
34. Beck C, Jimenez-Clavero MA, Leblond A, et al. Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease. Int J Environ Res Public Health 2013;10:6049-83
35. Racsa L, Gander R, Chung W, et al. Clinical features of West Nile virus epidemic in Dallas, Texas, 2012. Diagn Microbiol Infect Dis 2014;78:132-6
36. Anastasiadou A, Economopoulou A, Kakoulidis I, et al. Non-neuroinvasive West Nile virus infections during the outbreak in Greece. Clin Microbiol Infect 2011;17:1681-3
37. Barzon L, Pacenti M, Franchin E, et al. Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill 2012;17: pii:20260
38. Sejvar JJ. Clinical manifestations and outcomes of West Nile virus infection. Viruses 2014;6:606-23
39. Zou S, Foster GA, Dodd RY, et al. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis 2010;202:1354-61
40. Custer B, Kamel H, Kiely NE, et al. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion 2009;49:278-88
41. Orton SL, Stramer SL, Dodd RY. Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors. Transfusion 2006;46:272-7
42. Barzon L, Pacenti M, Franchin E, et al. Large human outbreak of West Nile virus infection in north-eastern Italy in 2012. Viruses 2013;5:2825-39
43. Sejvar JJ, Curns AT, Welburg L, et al. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol 2008;2:477-99
44. Garcia MN, Hause AM, Walker CM, et al. Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines. Viral Immunol 2014;27:327-33
45. Murray KO, Garcia MN, Rahbar MH, et al. Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort. PLoS One 2014;9:e102953
46. Hart J Jr, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis 2014;14:248
47. Popovic N, Milosevic B, Urosevic A, et al. Clinical characteristics and functional outcome of patients with West Nile neuroinvasive disease in Serbia. J Neurol 2014;261:1104-11
48. Anastasiadou A, Kakoulidis I, Butel D, et al. Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis 2013;17:e494-7
49. Nolan MS, Hause AM, Murray KO. Findings of long-term depression up to 8 years post infection from West Nile virus. J Clin Psychol 2012;68:801-8
50. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis outcome. Emerg Infect Dis 2006;12:514-16
51. Nolan MS, Podoll AS, Hause AM, et al. Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PLoS One 2012;7:e40374
52. Barzon L, Pacenti M, Palù G. West Nile virus and kidney disease. Expert Rev Anti Infect Ther 2013;11:479-87
53. Lim PY, Behr MJ, Chadwick CM, et al. Keratinocytes are cell targets of West Nile virus in vivo. J Virol 2011;85:5197-201
54. Johnston LJ, Halliday GM, King NJ. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J Invest Dermatol 2000;114:560-8
55. Verstrepen BE, Fagrouch Z, van Heteren M, et al. Experimental infection of rhesus macaques and common marmosets with a European strain of West Nile virus. PLoS Negl Trop Dis 2014;8:e2797.
56. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008;198:984-93.
57. Saxena V, Xie G, Li B, et al. A hamster-derived West Nile virus isolate induces persistent renal infection in mice. PLoS Negl Trop Dis 2013;7:e2275
58. Reisen WK, Padgett K, Fang Y, et al. Chronic infections of West Nile virus detected in California dead birds. Vector Borne Zoonotic Dis 2013;13:401-5
59. Wheeler SS, Vineyard MP, Woods LW, Reisen WK. Dynamics of West Nile virus persistence in House Sparrows (Passer domesticus). PLoS Negl Trop Dis 2012;6: e1860
60. Wheeler SS, Langevin SA, Brault AC, et al. Detection of persistent West Nile virus RNA in experimentally and naturally infected avian hosts. Am J Trop Med Hyg 2012;87:559-64
61. Murray K, Walker C, Herrington E, et al. Persistent infection with West Nile virus years after initial infection. J Infect Dis 2010;201:2-4
62. Gibney KB, Lanciotti RS, Sejvar JJ, et al. West Nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis 2011;203:344-7
63. Barzon L, Pacenti M, Franchin E, et al. Excretion of West Nile virus in urine during acute infection. J Infect Dis 2013;208:1086-92.
64. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005;353:460-7
65. Pupella S, Pisani G, Cristiano K, et al. West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety. Blood Transfus 2013;11:563-74
66. Lai L, Lee TH, Tobler L, et al. Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening. Transfusion 2012;52:447-54.
67. Lanteri MC, Lee TH, Wen L, et al. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion 2014;54:3232-41.
68. Rios M, Daniel S, Chancey C, et al. West Nile virus adheres to human red blood cells in whole blood. Clin Infect Dis 2007;45:181-6.
69. Barzon L, Pacenti M, Franchin E, et al. Isolation of West Nile virus from urine samples of patients with acute infection. J Clin Microbiol 2014;52:3411-13. Set-up of protocols for the isolation of WNV from urine samples.
70. Baty SA, Gibney KB, Staples JE, et al. Evaluation for West Nile virus (WNV) RNA in urine of patients within 5 months of WNV infection. J Infect Dis 2012;205:1476-7
71. Papa A, Testa T, Papadopoulou E. Detection of West Nile virus lineage 2 in the urine of acute human infections. J Med Virol 2014;86:2142-5
72. Cho H, Diamond MS. Immune responses to West Nile virus infection in the central nervous system. Viruses 2012;4:3812-30
73. Blau DM, Rabe IB, Bhatnagar J, et al. West Nile virus RNA in tissues from donor associated with transmission to organ transplant recipients. Emerg Infect Dis 2013;19:1518-20.
74. Winston DJ, Vikram HR, Rabe IB, et al. Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features. Transplantation 2014;97:881-9
75. Nett RJ, Kuehnert MJ, Ison MG, et al. Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis 2012;14:268-77
76. Costa AN, Capobianchi MR, Ippolito G, et al. West Nile virus: the Italian national transplant network reaction to an alert in the north-eastern region, Italy 2011. Euro Surveill 2011;16:pii: 19991
77. Prince HE, Tobler LH, Lapé-Nixon M, et al. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 2005;43:4316-20
78. Carson PJ, Prince HE, Biggerstaff BJ, et al. Characteristics of antibody responses in West Nile virus-seropositive blood donors. J Clin Microbiol 2014;52:57-60.
79. Prince HE, Tobler LH, Yeh C, et al. Persistence of West Nile virus-specific antibodies in viremic blood donors. Clin Vaccine Immunol 2007;14:1228-30
80. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003;9:376-9
81. ECDC. Available from: www.ecdc.europa. eu/en/healthtopics/west-nile-fever/EU-casedefinition/ Pages/EU-case-definition.aspx
82. CDC. Available from: wwwn.cdc.gov/NNDSS/script/casedef.aspx?CondYrID=946&DatePub=1/1/2014
83. Barzon L, Pacenti M, Franchin E, et al. Novel West Nile virus lineage 1a full genome sequences from human cases of infection in north-eastern Italy, 2011. Clin Microbiol Infect 2012;18:E541-4
84. Tilley PAG, Fox JD, Jayaraman GC, Preiksaitis JK. Nucleic acid testing for West Nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. J Infect Dis 2006;193:1361-4
85. Pai A, Kleinman S, Malhotra K, et al. Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay. Transfusion 2008;48:2184-9
86. Ziermann R, Sanchez-Guerrero SA. PROCLEIX West Nile virus assay based on transcription-mediated amplification. Expert Rev Mol Diagn 2008;8:239-45
87. Gaibani P, Pierro AM, Cavrini F, et al. False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection. J Clin Microbiol 2010;48:3338-9
88. Pisani G, Pupella S, Cristiano K, et al. Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing. Blood Transfus 2012;10:515-20
89. Scaramozzino N, Crance JM, Jouan A, et al. Comparison of flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences. J Clin Microbiol 2001;39:1922-7
90. Sánchez-Seco MP, Rosario D, Domingo C, et al. Generic RT-nested-PCR for detection of flaviviruses using degenerated primers and internal control followed by sequencing for specific identification. J Virol Methods 2005;126:101-9
91. Patel P, Landt O, Kaiser M, et al. Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses. Virol J 2013;10:58
92. Del Amo J, Sotelo E, Fernández-Pinero J, et al. A novel quantitative multiplex real-time RT-PCR for the simultaneous detection and differentiation of West Nile virus lineages 1 and 2, and of Usutu virus. J Virol Methods 2013;189:321-7
93. Barros SC, Ramos F, Zé-Zé L, et al. Simultaneous detection of West Nile and Japanese encephalitis virus RNA by duplex TaqMan RT-PCR. J Virol Methods 2013;193:554-7
94. Linke S, Mackay WG, Scott C, et al. Second external quality assessment of the molecular diagnostic of West Nile virus: are there improvements towards the detection of WNV? J Clin Virol 2011;52:257-60.
95. Barzon L, Pacenti M, Franchin E, et al. New endemic West Nile virus lineage 1a in northern Italy, July 2012. Euro Surveill 2012;17:pii: 20231
96. Brien JD, Lazear HM, Diamond MS. Propagation, quantification, detection, and storage of West Nile virus. Curr Protoc Microbiol 2013;31:15D.3.1-15D.3.18
97. Jayakeerthi RS, Potula RV, Srinivasan S, Badrinath S. Shell vial culture assay for the rapid diagnosis of Japanese encephalitis, West Nile and Dengue-2 viral encephalitis. Virol J 2006;3:2
98. Caceda ER, Kochel TJ. Application of modified shell vial culture procedure for arbovirus detection. PLoS One 2007;2: e1034
99. Akey DL, Brown WC, Dutta S, et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 2014;343:881-5
100. Edeling MA, Diamond MS, Fremont DH. Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci USA 2014;111:4285-90
101. Alcon S, Talarmin A, Debruyne M, et al. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002;40:376-81
102. Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000;38:1053-7
103. Macdonald J, Tonry J, Hall RA, et al. NS1 protein secretion during the acute phase of West Nile virus infection. J Virol 2005;79:13924-33
104. Saxena D, Kumar JS, Parida M, et al. Development and evaluation of NS1 specific monoclonal antibody based antigen capture ELISA and its implications in clinical diagnosis of West Nile virus infection. J Clin Virol 2013;58:528-34
105. Ding XX, Li XF, Deng YQ, et al. Development of a double antibody sandwich ELISA for West Nile virus detection using monoclonal antibodies against non-structural protein 1. PLoS One 2014;9:e108623
106. Prince HE, Calma J, Pham T, Seaton BL. Frequency of missed cases of probable acute West Nile virus (WNV) infection when testing for WNV RNA alone or WNV immunoglobulin M alone. Clin Vaccine Immunol 2009;16:587-8
107. De Filette M, Ulbert S, Diamond M, Sanders NN. Recent progress in West Nile virus diagnosis and vaccination. Vet Res 2012;43:16
108. Sambri V, Capobianchi MR, Cavrini F, et al. Diagnosis of West Nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses 2013;5:2329-48
109. Papa A, Karabaxoglou D, Kansouzidou A. Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus. J Med Virol 2011;83:1861-5
110. Sanchini A, Donoso-Mantke O, Papa A, et al. Second international diagnostic accuracy study for the serological detection of West Nile virus infection. PLoS Negl Trop Dis 2013;7:e2184.
111. Niedrig M, Donoso Mantke O, Altmann D, Zeller H. First international diagnostic accuracy study for the serological detection of West Nile virus infection. BMC Infect Dis 2007;7:72-6
112. Crill WD, Chang GJ. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 2004;78:13975-86
113. Throsby M, Geuijen C, Goudsmit J, et al. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J Virol 2006;80:6982-92
114. Oliphant T, Nybakken GE, Austin SK, et al. Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol 2007;81:11828-39
115. Beasley DW, Barrett AD. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 2002;76:13097-100
116. Ludolfs D, Niedrig M, Paweska JT, Schmitz H. Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans. Eur J Clin Microbiol Infect Dis 2007;26:467-73
117. Herrmann S, Leshem B, Lobel L, et al. T7 phage display of Ep15 peptide for the detection of WNV IgG. J Virol Methods 2007;141:133-40
118. Wong SJ, Boyle RH, Demarest VL, et al. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol 2003;41:4217-23
119. Crill WD, Trainor NB, Chang GJ. A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol 2007;88:1169-74
120. Roberson JA, Crill WD, Chang GJ. Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J Clin Microbiol 2007;10:3167-74
121. Vogt MR, Dowd KA, Engle M, et al. Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fc-gamma receptor and complement-dependent effector mechanisms. J Virol 2011;85:11567-80
122. Chabierski S, Barzon L, Papa A, et al. Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop. BMC Infect Dis 2014;14:246
123. Magurano F, Remoli ME, Baggieri M, et al. Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. Clin Microbiol Infect 2012;18:E545-7
124. Niedrig M, Sonnenberg K, Steinhagen K, Paweska JT. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. J Virol Method 2007;139:103-5
125. Prince HE, Lapé-Nixon M, Busch MP, et al. Utilization of follow-up specimens from viremic blood donors to assess the value of West Nile virus immunoglobulin G avidity as an indicator of recent infection. Clin Diagn Lab Immunol 2005;12:1123-6
126. Levett PN, Sonnenberg K, Sidaway F, et al. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol 2005;43:5873-5
127. Fox JL, Hazell SL, Tobler LH, Busch MP. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus. Clin Vaccine Immunol 2006;13:33-6
128. Chabierski S, Makert GR, Kerzhner A, et al. Antibody responses in humans infected with newly emerging strains of West Nile virus in Europe. PLoS One 2013;8:e66507
129. Roehrig JT, Hombach J, Barrett ADT. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol 2008;21:123-32
130. WHO, 2007. Guidelines for Plaque Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. WHO, Geneva, Switzerland
131. Taketa-Graham M, Powell Pereira JL, Baylis E, et al. High throughput quantitative colorimetric microneutralization assay for the confirmation and differentiation of West Nile Virus and St. Louis encephalitis virus. Am J Trop Med Hyg 2010;82:501-4
132. Di Gennaro A, Lorusso A, Casaccia C, et al. Serum neutralization assay can efficiently replace plaque reduction neutralization test for detection and quantitation of West Nile virus antibodies in human and animal serum samples. Clin Vaccine Immunol 2014;21:1460-2
133. Pugachev KV, Guirakhoo F, Mitchell F, et al. Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool. Am J Trop Med Hyg 2004;71:639-45
134. Johnson BW, Kosoy O, Hunsperger E, et al. Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests. Clin Vaccine Immunol 2009;16:1052-9
135. Maeda A, Maeda J. Review of diagnostic plaque reduction neutralization tests for flavivirus infection. Vet J 2013;1:33-40
136. Maeda J, Takagi H, Hashimoto S, et al. A PCR-based protocol for generating West Nile virus replicons. J Virol Methods 2008;148:244-52
137. Mattia K, Puffer BA, Williams KL, et al. Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One 2011;6:e27252
138. Svraka S, Rosario K, Duizer E, et al. Metagenomic sequencing for virus identification in a public-health setting. J Gen Virol 2010;91:2846-56
139. Barzon L, Lavezzo E, Militello V, et al. Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci 2011;12:7861-84
140. Barzon L, Lavezzo E, Costanzi G, et al. Next-generation sequencing technologies in diagnostic virology. J Clin Virol 2013;58:346-50
141. Hall RJ, Wang J, Todd AK, et al. Evaluation of rapid and simple techniques for the enrichment of viruses prior to metagenomic virus discovery. J Virol Methods 2014;195:194-204
142. Malboeuf CM, Yang X, Charlebois P, et al. Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification. Nucleic Acids Res 2013;41:e13
143. Thai KT, Henn MR, Zody MC, et al. High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections. J Virol 2012;86(2):835-43
144. Foord AJ, Boyd V, White JR, et al. Flavivirus detection and differentiation by a microsphere array assay. J Virol Methods 2014;203:65-72
145. Wolk DM, Kaleta EJ, Wysocki VH. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn 2012;14:295-304
146. Deyde VM, Sampath R, Gubareva LV. RT-PCR/electrospray ionization mass spectrometry approach in detection and characterization of influenza viruses. Expert Rev Mol Diagn 2011;11:41-52
147. Grant-Klein RJ, Baldwin CD, Turell MJ, et al. Rapid identification of vector-borne flaviviruses by mass spectrometry. Mol Cell Probes 2010;24:219-28
148. Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol 2013;30:2725-9